Literature DB >> 11976792

CARD15 gene and the classification of Crohn's disease.

Laura Murillo1, J Bart A Crusius, Ad A van Bodegraven, Behrooz Z Alizadeh, A Salvador Peña.   

Abstract

An insertion mutation at nucleotide 3020 (3020insC) in the CARD15 gene, originally reported as NOD2, has been strongly associated with Crohn's disease. The CARD15 G2722C missense mutation was also shown to be associated with this disease. We studied 130 Dutch Crohn's disease patients, with a median follow up of 9.2 years, in relation to the Vienna classification, and 152 ethnically matched healthy controls. We confirm reports that the CARD15 3020insC mutation increases the susceptibility to Crohn's disease, but we do not confirm this relationship for CARD15 G2722C. Our findings suggest that these mutations are not a marker of a particular form of Crohn's disease according to the Vienna classification. Whether the CARD153020insC and CARD15 G2722C mutations are responsible for a different etiopathogenic mechanism in a subgroup of patients remains to be studied.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11976792     DOI: 10.1007/s00251-002-0440-1

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  15 in total

1.  The inflammasome: in memory of Dr. Jurg Tschopp.

Authors:  M Dagenais; A Skeldon; M Saleh
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

Review 2.  Genotypes and phenotypes in Crohn's disease: do they help in clinical management?

Authors:  C Gasche; P Grundtner
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

3.  CARD15 genotype-phenotype relationships in a small inflammatory bowel disease population with severe disease affection status.

Authors:  Nigel P S Crawford; Daniel W Colliver; M Robert Eichenberger; Alisa A Funke; Valentina Kolodko; Gary A Cobbs; Robert E Petras; Susan Galandiuk
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

4.  1007fs, G908R, R702W mutations and P268S, IVS8+158 polymorphisms of the CARD15 gene in Turkish inflammatory bowel disease patients and their relationship with disease-related surgery.

Authors:  Ali Tüzün Ince; Ozden Hatirnaz; Oya Ovünç; Uğur Ozbek
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

5.  Contribution of genetics to a new vision in the understanding of inflammatory bowel disease.

Authors:  A S Peña
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

6.  The relation between NOD2/CARD15 mutations and the prevalence and phenotypic heterogeneity of Crohn's disease: lessons from the Israeli Arab Crohn's disease cohort.

Authors:  Amir Karban; Oren Atia; Eran Leitersdorf; Azmi Shahbari; Wisam Sbeit; Zvi Ackerman; Rawia Mualem; Arie Levine; Shula Nesher; Rifaat Safadi; Rami Eliakim
Journal:  Dig Dis Sci       Date:  2005-09       Impact factor: 3.199

7.  Prediction of Crohn's disease aggression through NOD2/CARD15 gene sequencing in an Australian cohort.

Authors:  Maneesha Bhullar; Finlay Macrae; Gregor Brown; Margie Smith; Ken Sharpe
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

8.  A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews.

Authors:  Kazuhito Sugimura; Kent D Taylor; Ying-chao Lin; Tieu Hang; Dai Wang; Yong-Ming Tang; Nathan Fischel-Ghodsian; Stephan R Targan; Jerome I Rotter; Huiying Yang
Journal:  Am J Hum Genet       Date:  2003-02-07       Impact factor: 11.025

Review 9.  Progress in searching for susceptibility gene for inflammatory bowel disease by positional cloning.

Authors:  Chang-Qing Zheng; Gang-Zheng Hu; Zhao-Shu Zeng; Lian-Jie Lin; Gin-Ge Gu
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

Review 10.  Genetic and pathogenetic insights into inflammatory bowel disease.

Authors:  Francesco Pallone; Giovanna Del Vecchio Blanco; Piero Vavassori; Ivan Monteleone; Daniele Fina; Giovanni Monteleone
Journal:  Curr Gastroenterol Rep       Date:  2003-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.